HIGHLIGHTS
- who: Manuela Montanaro and collaborators from the Department of Experimental Medicine, Tor Vergata Oncoscience Research (TOR), University of Rome Tor Vergata, Rome, Italy have published the research work: ZNF750: A Novel Prognostic Biomarker in Metastatic Prostate Cancer, in the Journal: (JOURNAL) of 30/03/2023
- what: The aim of this study was to investigate whether could have role in better stratifying patients identifying those with higher risk of metastasis and with the poorest prognosis. Given this, studies havehealth proposed new markers and/or targets for process, arerecent considered a major challenge.
- how: Data . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.